...
首页> 外文期刊>World journal of urology >Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease
【24h】

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease

机译:ICUD-SIU咨询对2016年上行核癌癌的ICUD-SIU咨询:局部高危疾病的治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To provide a comprehensive overview and update of the joint consultation of the International Consultation on Urological Diseases (ICUD) and Société Internationale d’Urologie for the treatment of localized high-risk upper tract urothelial carcinoma (UTUC). Methods: A detailed analysis of the literature was conducted reporting on treatment modalities and outcomes in localized high-risk UTUC. An international, multidisciplinary expert committee evaluated and graded the data according to the Oxford System of Evidence-based Medicine modified by the ICUD. Results: Radical nephroureterectomy (RNU) is the standard of treatment for high-grade or clinically infiltrating UTUC and includes the removal of the entire kidney, ureter and ipsilateral bladder cuff. The distal ureter can be managed either by extravesical or transvesical approach, whereas endoscopically assisted procedures are associated with decreased intravesical recurrence-free survival. Post-operative intravesical chemotherapy decreases the risk of subsequent bladder tumour recurrence. Regional lymph node dissection is of prognostic importance in infiltrative UTUC, but its extent has not been standardized. Renal-sparing surgery is an option for manageable, high-grade tumours of any part of the upper tract, especially of the distal ureter, as an alternative to RNU. Endoscopy-based renal-sparing procedures are associated with a higher risk of recurrence and progression. Conclusions: A multimodal approach should be considered in localized high-risk UTUC to improve outcomes. RNU is the standard of treatment in high-risk disease. Renal-sparing approaches may be oncologically equivalent alternatives to RNU in well-selected patients, especially in those with distal ureteric tumours. ? 2016, Springer-Verlag Berlin Heidelberg.
机译:目的:提供全面概述和更新国际泌尿外疾病(ICUD)和SociétéInternationaled'ulologie的联合协商,用于治疗局部高风险的高风险尿路上皮癌(UTUC)。方法:对文献进行了详细分析,对局部高风险UTUC中的治疗方式和结果进行了报告。根据ICUD修改的基于循证医学系统的牛津系统评估和评分数据。结果:自由基肾感性切除术(RNU)是高档或临床渗透utuc的治疗标准,包括除去整个肾,输尿管和膀胱囊箍。远端输尿管可以通过外部或跨越方法来管理,而内窥镜辅助程序与无膀胱内复发存活率有关。术后膀胱内化疗降低了随后的膀胱肿瘤复发的风险。区域淋巴结解剖在渗透尾部具有预后重要性,但其程度尚未标准化。肾脏备件手术是上部内部任何部分的可管理,高级肿瘤的一种选择,特别是远端输尿管,作为RNU的替代品。基于内窥镜检查的肾脏制备程序与更高的复发和进展有关。结论:在局部高风险的utuc术中应考虑多峰方法以改善结果。 RNU是高危病症的治疗标准。肾脏备件方法可能是初始患者RNU的型替代品,特别是在远端输尿管肿瘤的患者中。还2016年,Springer-Verlag Berlin Heidelberg。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号